CNCure
CNCure is a biotech company in Hwasun, South Korea, founded in 2019. It has raised $12.0M across 1 round.
See & Cure !
- Headquarters
- Hwasun
- Founded
- 2019
- Business Model
- B2B
- Website
- cncure.co.kr
- Total Funding
- $12.0M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
CNCure Biotech develops immuno-theranostic platforms that combine microbial-based cancer therapy, molecular imaging, and radio-theranostics for precision medicine. Its microbial-based cancer therapy uses SAM and microbiome platforms to target tumors, while AICureX applies AI to drug-candidate screening. Founded in 2019, the company is based at the National Immunotherapy Innovation Center in Hwasun, South Korea, and is advancing clinical-stage radiopharmaceutical and bacterial cancer-therapy programs.
Summary
It has raised $12.0M in total across 1 round. Investors include Hana Ventures, Johnson & Johnson Innovation and ID ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cncure"><img src="https://indexed.vc/api/badge/company/cncure" alt="CNCure on Indexed.vc" width="260" height="76" /></a>